Multicell Techs Inc

(MCET)

By |

Profile

MultiCell Technologies Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer and others. Its therapeutic development platform includes several patented techniques used to isolate, characterize and differentiate stem cells from human liver or control the immune response at transcriptional and translational levels through dsRNA-sensing molecules, such as Toll-like receptor, RIG-I-like receptor, and MDA-5 signaling. The company's medical device development platform is based on the design of a next-generation bioabsorbable stent, the Ideal BioStent, for interventional cardiology and peripheral vessel applications. All the operations are functioned within United States.

Contact Information

Website: www.multicelltech.com
Email: MCETinvestor@Multicelltech.com
Main Phone: +1 401 762-0045
Address: 68 Cumberland Street
Address 2: Suite 301
State: RI
City / Town: Woonsocket
Country: USA
Postal Code: 02895

Issuer Information

Exchange: OTO
CEO: W. Gerald Newmin
Employees: 2
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.0001 $ 0. (0.00%)
Last Price 0.0001 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.0001
Last Trade Volume 0 52 Wk Hi 0.0002 52 Wk Low 0.
Market Cap 500,095 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 5,000,948,700.00 EPS (TTM) 0.00 PE Ratio 1.30 Exchange OTCPK